Rabies virus glycoprotein 29 (RVG29) promotes CAR-T immunotherapy for glioma-Reference-Cited by-同舟云学术

Rabies virus glycoprotein 29 (RVG29) promotes CAR-T immunotherapy for glioma

Published:2023-09 Issue: Volume:259 Page:1-12
ISSN:1931-5244
Container-title:Translational Research
language:en
Short-container-title:Translational Research

Author:

Ji Feng^ORCID,Xu Luxia,Long Kaili,Zhang Fan,Zhang Miaomiao,Lu Xiao,Xia Mingyue,Chen Jiannan,Du Yu,Tang Yong,Wu Heming,Shi Yan,Ma Ruiting,Li Jun,Chen Zhengliang,Xu Bin,zhang Qi,Liang Junqing,Jia Shaochang,Hu Zhigang,Guo Zhigang

Funder

Priority Academic Program Development of Jiangsu Higher Education Institutions

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference49 articles.

1. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment;van Tellingen;Drug Resist Update,2015

2. Cellular origin of glioblastoma and its implication in precision therapy;Yao;Cell Mol Immunol,2018

3. A microfluidic cell-migration assay for the prediction of progression-free survival and recurrence time of patients with glioblastoma;Wong;Nat Biomed Eng,2021

4. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia;Grupp;New Engl J Med,2013

5. Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma;Bielamowicz;Neuro-Oncology,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD70 CAR-T cells empowered by TS-2021 through ex vivo transduction show potent antitumor efficacy against glioblastoma;Journal of Experimental & Clinical Cancer Research;2025-06-05

2. B4M3 CAR-T cell enhance antitumor activity and non-tumor toxicity in ovarian cancer;International Immunopharmacology;2025-06

3. The nanocarrier strategy for crossing the blood-brain barrier in glioma therapy;Chinese Chemical Letters;2025-04

4. RVG29-modified oncolytic herpes simplex virus for intracranial tumor treatment;Nano Today;2025-04

5. Sodium citrate pretreatment enhances CAR-T cell persistence and anti-tumor efficacy through inhibition of calcium signaling;Frontiers in Immunology;2025-03-17